Injection site study for a new medicine in healthy people
This study tests a medicine called pegozafermin, given as a small injection just under the skin. Researchers want to see how the body absorbs the medicine depending on where the injection is given (like belly vs. thigh). It is an early-stage study in healthy people to help guide future use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult, as confirmed by a medical check-up.
- Your body mass index (BMI) is between 18.5 and 35.
- You have no history of pancreatitis, gallbladder disease, high blood pressure, or significant menstrual problems.
- You have no tattoos or scars on your belly or thighs where the injection would be given.
- You have never had cancer, and you do not drink more than a moderate amount of alcohol.
- You are not pregnant, planning to become pregnant, or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.
This study tests a new medicine called ZP9830 to see if it is safe for people and how it works in the body. Healthy volunteers aged 18 to 45 can join.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
This study tests a new medicine called Efsubaglutide Alfa in healthy adults. It is a first-in-human study to see how the drug is absorbed, broken down, and eliminated by the body. This study is for healthy volunteers only, not patients.
This is an early study testing a new medicine called CIT-013. It is given as an injection under the skin, and the goal is to see if it is safe and how the body handles it. It is for healthy volunteers.
This trial tests a new drug called QLS2312, given as an injection, to see if it is safe and how the body handles it. It is an early study in healthy volunteers that helps decide if the drug can be studied in people with certain conditions.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.